Literature DB >> 22710350

Influenza virus infection in guinea pigs raised as livestock, Ecuador.

Victor H Leyva-Grado1, Samira Mubareka, Florian Krammer, Washington B Cárdenas, Peter Palese.   

Abstract

To determine whether guinea pigs are infected with influenza virus in nature, we conducted a serologic study in domestic guinea pigs in Ecuador. Detection of antibodies against influenza A and B raises the question about the role of guinea pigs in the ecology and epidemiology of influenza virus in the region.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22710350      PMCID: PMC3376804          DOI: 10.3201/eid1807.111930

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


Influenza A virus infection causes disease in humans and domestic animals, including pigs, horses, and chickens, and seasonal epidemics among humans in the Northern and Southern Hemispheres result in hospitalizations and deaths worldwide. Influenza A virus transmission studies are often conducted in laboratory guinea pigs (1,2) because the virus can efficiently spread from infected animals to naive guinea pigs by direct and indirect (short-range infectious aerosols) contact (3,4). However, whether guinea pigs are naturally infected with influenza virus outside the laboratory setting is not known. In some regions of South America, guinea pigs are part of the traditional cuisine and are produced as livestock and sold commercially for human consumption. Guinea pigs are customarily raised on small rural farms in proximity to other livestock. Circulation of influenza virus in these populations has not been studied. Given the effect of influenza virus on human health and the susceptibility of guinea pigs to influenza virus infection in the laboratory, it is worthwhile to determine whether influenza virus can spread among guinea pigs in agricultural settings. As an initial step in this endeavor, we obtained serum samples from domestic guinea pigs in Ecuador and tested them for the presence of influenza antibodies to determine whether the guinea pigs had been infected with influenza virus.

The Study

We obtained serum samples from 40 guinea pigs from 3 different regions of Ecuador (Figure 1), 20 from Cuenca and 10 each from Guayaquil and the Manabí region. Cuenca is located in the Andes region, 2,500 m above sea level; it is one of the main producers of guinea pig meat. Guayaquil, the most populated city in Ecuador, is located at the head of the Gulf of Guayaquil on the Pacific Ocean. The Manabí region is located in western Ecuador on the Pacific Ocean coast. Serum samples were collected from adult guinea pigs that we purchased from local farms (Cuenca), where they had been raised as livestock, or from live animal markets (Guayaquil and Manabí). The samples were collected by heart puncture under general anesthesia (combination of ketamine and xylazine). Animals were euthanized after samples were obtained.
Figure 1

Three regions of Ecuador where guinea pig serum samples were obtained: Cuenca, Guayaquil, and Manabi. The country is bordered by Colombia to the north, Peru to the east and south, and the Pacific Ocean to the west. Cuenca is located in the Andes; the average annual mean temperature is 14.7°C, and the average annual relative humidity is 85%. Guayaquil is located at the head of the Gulf of Guayaquil; the mean temperature is 26.1°C, and relative humidity is 74%. The Manabí region is located on the Pacific Ocean coast; the mean temperature is 25.9°C, and relative humidity is 79%.

Three regions of Ecuador where guinea pig serum samples were obtained: Cuenca, Guayaquil, and Manabi. The country is bordered by Colombia to the north, Peru to the east and south, and the Pacific Ocean to the west. Cuenca is located in the Andes; the average annual mean temperature is 14.7°C, and the average annual relative humidity is 85%. Guayaquil is located at the head of the Gulf of Guayaquil; the mean temperature is 26.1°C, and relative humidity is 74%. The Manabí region is located on the Pacific Ocean coast; the mean temperature is 25.9°C, and relative humidity is 79%. For antigens in the serologic analyses, we used whole viruses and recombinant hemagglutinin, nucleoprotein, and neuraminidase (subtypes N1 and N2) proteins produced in our laboratory as described (5,6). The whole viruses were A/Brisbane/59/2007 (H1N1) (Brisbane07), A/New Caledonia/20/1999 (H1N1) (Newcal99), A/Wisconsin/67/2005 (H3N2) (Wisconsin05), A/Vietnam/1203/2004 (H5N1) (Vietnam04), and B/Yamagata/16/1988 (Yamagata88). The hemagglutinins were A/California/04/2009 (Cal09), NewCal99, Vietnam04, Wisconsin05, and Yamagata88. The nucleoproteins were Brisbane07, A/Puerto Rico/08/1934, and B/Florida/04/2006. The subtype N1 neuraminidases were Cal09 and Vietnam04; the N2 subtype was A/Hong Kong/1/1968. ELISA was done as described (7), with slight modifications for the use of guinea pig serum. The cutoff for serum considered positive for influenza virus was the value of the negative control (naive guinea pig serum) +3 SD (from 3 repetitions). For Western blot (WB) analyses (8), serum samples were pooled into groups of 5 (groups 1–4, 5–6, and 7–8 were from Cuenca, Guayaquil, and Manabí region, respectively). Pooled samples were also used for the hemagglutination inhibition (HI) assay, as described (9), using influenza strains Brisbane07, Wisconsin05, and Vietnam04. As positive controls, we used serum from guinea pigs that we had infected with Cal09, Brisbane07, NewCal99, Wisconsin05, Vietnam04, or Yamagata88. ELISA results for the 40 serum samples showed that 20, 18, and 14 were positive for influenza subtypes H1, H3, and H5, respectively (Table 1). The samples were also tested for the presence of antibodies against the influenza virus nucleoprotein: results for 29 were positive. Samples with positive results to >1 hemagglutinin antigens and to nucleoprotein were also analyzed for the presence of antibodies against proteins of the neuraminidase subtypes N1 (Cal09, Vietnam04) and N2 (influenza A/Hong Kong/1/1968 [H3N2]) (Table 1). Serum samples were also tested for the presence of influenza B virus by using whole virus, recombinant hemagglutinin, and recombinant nucleoprotein as described above. Samples from Cuenca showed the highest overall positivity to the 3 antigens (Table 2).
Table 1

ELISA results for the presence of influenza A virus antibodies in guinea pigs from different regions of Ecuador*

RegionNo. (%) positive, by antigen†
H1H3H5NPN1 (Cal09)N1 (Vietnam04)N2
Cuenca, n = 2011 (55)12 (60)6 (30)16 (80)8 (57)‡8 (57)‡10 (71)
Guayaquil, n = 108 (80)5 (50)8 (80)10 (100)8 (88)§8 (88)§8 (88)§
Manabí, n = 101 (10)1 (10)03 (30)1 (50)¶1 (50)¶
Total20181429171718

*Samples were from adult guinea pigs raised as livestock on local farms (Cuenca) or from live animal markets (Guayaquil and Manabí). H1, recombinant hemagglutinin from A/California/04/2009 (Cal09); H3, recombinant hemagglutinin from A/Wisconsin/67/2005; H5, recombinant hemagglutinin from A/Vietnam/1203/2004 (Vietnam04); NP, recombinant nucleoprotein from A/Brisbane/10/2007; N1, recombinant neuraminidase from Cal09 or Vietnam04; N2, recombinant neuraminidase from A/Hong Kong/1/1968.
†Serum samples were considered positive if absorbance (read at 405 nm) was higher than the value of the negative control (naive guinea pig serum) +3 SD.
‡Only 14 samples were tested.
§Only 9 samples were tested.
¶Only 2 samples were tested.

Table 2

ELISA results for the presence of influenza B virus antibodies in guinea pigs from different regions of Ecuador*

RegionNo. (%) positive, by antigen†
Whole virus (Yamagata88)Recombinant hemagglutininRecombinant nucleoprotein
Cuenca, n = 2017 (85)18 (90)18 (94)‡
Guayaquil, n = 108 (80)9 (90)9 (90)
Manabí, n =102 (20)1 (1)1 (10)
Total272828

*Samples were from adult guinea pigs raised as livestock on local farms (Cuenca) or from live animal markets (Guayaquil and Manabí). Whole virus, B/Yamagata/16/1988. Recombinant hemagglutinin was derived from B/Florida/04/2006; nucleoprotein was derived from B/Yamagata/16/1988.
†Serum samples were considered positive if absorbance (read at 405 nm) was higher than the value of the negative control (naive guinea pig serum) + 3 SD.
‡Only 19 samples were tested.

*Samples were from adult guinea pigs raised as livestock on local farms (Cuenca) or from live animal markets (Guayaquil and Manabí). H1, recombinant hemagglutinin from A/California/04/2009 (Cal09); H3, recombinant hemagglutinin from A/Wisconsin/67/2005; H5, recombinant hemagglutinin from A/Vietnam/1203/2004 (Vietnam04); NP, recombinant nucleoprotein from A/Brisbane/10/2007; N1, recombinant neuraminidase from Cal09 or Vietnam04; N2, recombinant neuraminidase from A/Hong Kong/1/1968.
†Serum samples were considered positive if absorbance (read at 405 nm) was higher than the value of the negative control (naive guinea pig serum) +3 SD.
‡Only 14 samples were tested.
§Only 9 samples were tested.
¶Only 2 samples were tested. *Samples were from adult guinea pigs raised as livestock on local farms (Cuenca) or from live animal markets (Guayaquil and Manabí). Whole virus, B/Yamagata/16/1988. Recombinant hemagglutinin was derived from B/Florida/04/2006; nucleoprotein was derived from B/Yamagata/16/1988.
†Serum samples were considered positive if absorbance (read at 405 nm) was higher than the value of the negative control (naive guinea pig serum) + 3 SD.
‡Only 19 samples were tested. WB analysis of pooled samples from the 3 areas confirmed the ELISA results that showed antibodies against the hemagglutinin and nucleoprotein antigens; however, samples from Manabí region (7,8) showed immunoreactivity to the H3 antigen only (Figure 2). WB results for serum samples from Cuenca and Guayaquil were positive for influenza B virus, but results were not positive for samples from Manabí when whole virus was used as antigen (Figure 2). HI activity was observed in all pooled samples against all 3 viruses tested. Titers were highest in samples from Cuenca (320 for Brisbane07, 640 for Wisconsin05, and 80 for Vietnam04) and lowest for samples from Manabí (80 for Brisbane07 and 40 for Wisconsin05 and Vietnam04). Titers for samples from Guayaquil were 160 for Brisbane07 and 80 for Wisconsin05 and Vietnam04.
Figure 2

Results of Western blot analyses of pooled serum samples from adult guinea pigs in Ecuador. The guinea pigs were obtained from farms in Cuenca, where they had been raised as livestock, or from live animal markets in Guayaquil and Manabí. The results show different influenza antigens: recombinant hemagglutinin (rHA) A/New Caledonia/20/1999 (A); rHA A/Wisconsin/67/2005 (B); rHA A/Vietnam/1203/2004 (C); recombinant nucleoprotein A/Puerto Rico/08/1934 (D); and B virus (whole virus B/Yamagata/16/1988) (E). Molecular weights are shown at left. (+), serum from guinea pigs infected in the laboratory with influenza virus; (−), serum from naive guinea pig; lanes 1–4, pooled serum samples from Cuenca; lanes 5–6, pooled serum samples from Guayaquil; lanes 7–8, pooled serum samples from Manabí; S, secondary antibody only.

Results of Western blot analyses of pooled serum samples from adult guinea pigs in Ecuador. The guinea pigs were obtained from farms in Cuenca, where they had been raised as livestock, or from live animal markets in Guayaquil and Manabí. The results show different influenza antigens: recombinant hemagglutinin (rHA) A/New Caledonia/20/1999 (A); rHA A/Wisconsin/67/2005 (B); rHA A/Vietnam/1203/2004 (C); recombinant nucleoprotein A/Puerto Rico/08/1934 (D); and B virus (whole virus B/Yamagata/16/1988) (E). Molecular weights are shown at left. (+), serum from guinea pigs infected in the laboratory with influenza virus; (−), serum from naive guinea pig; lanes 1–4, pooled serum samples from Cuenca; lanes 5–6, pooled serum samples from Guayaquil; lanes 7–8, pooled serum samples from Manabí; S, secondary antibody only.

Conclusions

We showed the presence of influenza virus antibodies with HI activity to different virus subtypes in guinea pigs marketed through local farms and live animal markets in different regions of Ecuador. Seroprevalence was similar for influenza A virus subtypes H1 (50%) and H3 (45%). A study of influenza among humans in Ecuador also showed similar seroprevalences for subtypes H1 (5.1%) and H3 (5.5%) (10). This10-fold difference between seroprevalence rates among humans and the guinea pigs in our study may be explained by animal husbandry practices that facilitate influenza transmission (e.g., the crowding of animals in cages). The presence of antibodies to influenza B virus in guinea pigs is notable because infection with this virus is thought to be restricted to humans (11). Recent studies in our laboratory demonstrated that guinea pigs can also be infected with influenza B viruses and that they readily transmit the virus to naive guinea pigs (12). These studies support our finding that influenza B virus has the potential to be transmitted from humans to other species. Further studies are needed to isolate and characterize the type B influenza virus present in the population of guinea pigs to determine if there has been an adaptation to the new host or if the guinea pig is only a transient reservoir for the human virus. We found that several guinea pigs had antibodies against influenza A (H5). Ecuador is purported to be free of avian influenza (13); however, reports from other countries in South America demonstrate the presence of avian subtypes H3, H5N2, H7N3, and H13N9 in wild birds (14). In addition, chickens, turkeys, and guinea pigs that are later sold in local farmers’ markets are raised together by some families, thereby facilitating contact of guinea pigs with avian influenza viruses. We tested only for seroreactivity to the H5 hemagglutinin and the N1 neuraminidase; therefore, further studies are needed to determine whether different avian origin influenza viruses are present in the guinea pig population. We did not determine whether guinea pigs are an incidental host for influenza virus infection or, if instead, the virus has been adapted to these animals or if guinea pigs are a natural reservoir for some influenza viruses. To this end, virus isolation and characterization would be necessary to determine the virus strains circulating in this population. In the laboratory, guinea pigs are infected and efficiently transmit influenza viruses to naive hosts without showing any overt clinical signs of disease (1). Therefore, further studies are needed to address the specific role of guinea pigs raised as livestock in the ecology and epidemiology of influenza viruses in the region.
  13 in total

Review 1.  Molecular studies of influenza B virus in the reverse genetics era.

Authors:  David Jackson; Ruth A Elderfield; Wendy S Barclay
Journal:  J Gen Virol       Date:  2010-10-06       Impact factor: 3.891

Review 2.  Avian influenza in North and South America, the Caribbean, and Australia, 2006-2008.

Authors:  Dennis A Senne
Journal:  Avian Dis       Date:  2010-03       Impact factor: 1.577

3.  Transmission of influenza B viruses in the guinea pig.

Authors:  Natalie Pica; Yi-Ying Chou; Nicole M Bouvier; Peter Palese
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

4.  Trichoplusia ni cells (High Five) are highly efficient for the production of influenza A virus-like particles: a comparison of two insect cell lines as production platforms for influenza vaccines.

Authors:  Florian Krammer; Theresa Schinko; Dieter Palmberger; Christopher Tauer; Paul Messner; Reingard Grabherr
Journal:  Mol Biotechnol       Date:  2010-07       Impact factor: 2.695

5.  Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes.

Authors:  Taia T Wang; Gene S Tan; Rong Hai; Natalie Pica; Lily Ngai; Damian C Ekiert; Ian A Wilson; Adolfo García-Sastre; Thomas M Moran; Peter Palese
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-18       Impact factor: 11.205

6.  Guinea pig model for evaluating the potential public health risk of swine and avian influenza viruses.

Authors:  Yipeng Sun; Yuhai Bi; Juan Pu; Yanxin Hu; Jingjing Wang; Huijie Gao; Linqing Liu; Qi Xu; Yuanyuan Tan; Mengda Liu; Xin Guo; Hanchun Yang; Jinhua Liu
Journal:  PLoS One       Date:  2010-11-23       Impact factor: 3.240

7.  High temperature (30 degrees C) blocks aerosol but not contact transmission of influenza virus.

Authors:  Anice C Lowen; John Steel; Samira Mubareka; Peter Palese
Journal:  J Virol       Date:  2008-03-26       Impact factor: 5.103

8.  Blocking interhost transmission of influenza virus by vaccination in the guinea pig model.

Authors:  Anice C Lowen; John Steel; Samira Mubareka; Elena Carnero; Adolfo García-Sastre; Peter Palese
Journal:  J Virol       Date:  2009-01-19       Impact factor: 5.103

9.  Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses.

Authors:  Natalie Pica; Rong Hai; Florian Krammer; Taia T Wang; Jad Maamary; Dirk Eggink; Gene S Tan; Jens C Krause; Thomas Moran; Cheryl R Stein; David Banach; Jens Wrammert; Robert B Belshe; Adolfo García-Sastre; Peter Palese
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

10.  Sentinel surveillance of influenza-like-illness in two cities of the tropical country of Ecuador: 2006-2010.

Authors:  Richard W Douce; Washington Aleman; Wilson Chicaiza-Ayala; Cesar Madrid; Merly Sovero; Franklin Delgado; Mireya Rodas; Julia Ampuero; Gloria Chauca; Juan Perez; Josefina Garcia; Tadeusz Kochel; Eric S Halsey; V Alberto Laguna-Torres
Journal:  PLoS One       Date:  2011-08-24       Impact factor: 3.240

View more
  9 in total

Review 1.  Animal models for influenza virus transmission studies: a historical perspective.

Authors:  Nicole M Bouvier
Journal:  Curr Opin Virol       Date:  2015-06-28       Impact factor: 7.090

2.  Influenza A virus polymerase is a site for adaptive changes during experimental evolution in bat cells.

Authors:  Daniel S Poole; Shuǐqìng Yú; Yíngyún Caì; Jorge M Dinis; Marcel A Müller; Ingo Jordan; Thomas C Friedrich; Jens H Kuhn; Andrew Mehle
Journal:  J Virol       Date:  2014-08-20       Impact factor: 5.103

3.  Domestic pigs are susceptible to infection with influenza B viruses.

Authors:  Zhiguang Ran; Huigang Shen; Yuekun Lang; Elizabeth A Kolb; Nuri Turan; Laihua Zhu; Jingjiao Ma; Bhupinder Bawa; Qinfang Liu; Haixia Liu; Megan Quast; Gabriel Sexton; Florian Krammer; Ben M Hause; Jane Christopher-Hennings; Eric A Nelson; Juergen Richt; Feng Li; Wenjun Ma
Journal:  J Virol       Date:  2015-02-11       Impact factor: 5.103

4.  Reassortment complements spontaneous mutation in influenza A virus NP and M1 genes to accelerate adaptation to a new host.

Authors:  William L Ince; Aissatou Gueye-Mbaye; Jack R Bennink; Jonathan W Yewdell
Journal:  J Virol       Date:  2013-01-30       Impact factor: 5.103

5.  Expression of functional recombinant hemagglutinin and neuraminidase proteins from the novel H7N9 influenza virus using the baculovirus expression system.

Authors:  Irina Margine; Peter Palese; Florian Krammer
Journal:  J Vis Exp       Date:  2013-11-06       Impact factor: 1.355

6.  Methicillin resistant Staphylococcus aureus carriage among guinea pigs raised as livestock in Ecuador.

Authors:  Marlon Zambrano-Mila; Angel S Rodriguez; Ismar A Rivera-Olivero; Mauricio Salas-Rueda; Marco Vinicio Caceres-Orellana; Jacobus H de Waard; Miguel Angel Garcia-Bereguiain
Journal:  One Health       Date:  2019-11-29

7.  Selective usage of ANP32 proteins by influenza B virus polymerase: Implications in determination of host range.

Authors:  Zhenyu Zhang; Haili Zhang; Ling Xu; Xing Guo; Wenfei Wang; Yujie Ji; Chaohui Lin; Yujie Wang; Xiaojun Wang
Journal:  PLoS Pathog       Date:  2020-10-12       Impact factor: 6.823

8.  Serosurveillance for pandemic influenza A (H1N1) 2009 virus infection in domestic elephants, Thailand.

Authors:  Weena Paungpin; Witthawat Wiriyarat; Kridsada Chaichoun; Ekasit Tiyanun; Nareerat Sangkachai; Don Changsom; Kanaporn Poltep; Parntep Ratanakorn; Pilaipan Puthavathana
Journal:  PLoS One       Date:  2017-10-26       Impact factor: 3.240

Review 9.  Transmission in the guinea pig model.

Authors:  Anice C Lowen; Nicole M Bouvier; John Steel
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.